usbureau nation institut health usbureau doctitl prospect grant exclus licens calanolid antivir compound composit use thereof doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari notic accord 15 u c 209 c 1 37 cfr 404 7 1 nation institut health nih depart health human servic contempl grant exclus world wide licens practic invent embodi u patent applic sn 07 861 249 08 065 618 entitl calanolid antivir compound composit use thereof relat foreign patent applic medichem research inc lemont il patent right invent assign unit state america prospect exclus licens royalti bear compli term condit 35 u c 209 37 cfr 404 7 anticip licens may limit field treatment aid prospect exclus licens may grant unless within 60 day date publish notic nih receiv written evid argument establish grant licens would consist requir 35 u c 209 37 cfr 404 7 patent applic describ chemic structur method isol purifi coumarin extract tropic rain forest tree calophyllum langerum relat speci genu calophyllum teysmannii new class compound analog also refer calanolid costatolid respect strongli inhibit hiv1 replic cytopath vitro compound may advantag pharmacolog toxicolog antivir properti especi treatment aid summari address address request copi patent applic inquiri comment materi relat contempl licens direct steven ferguson technolog licens specialist offic technolog transfer nation institut health 6011 execut boulevard suit 325 rockvil md 20852 telephon 301 4967735 facsimil 301 4020220 e mail steve x ferguson nihod601 applic licens file respons notic treat object grant contempl licens written comment applic licens receiv nih within sixti 60 day notic consid sign confidenti disclosur agreement requir receiv copi patent applic date august 20 1994 address signer barbara mcgarey signer signjob deputi director offic technolog transfer signjob frfile fr doc 9421519 file 83094 8 45 frfile bill bill code 414001p bill